PAFAH1B1 and metabolic dysfunction-associated steatotic liver disease: Although no animal model recapitulates the entire disease spectrum of NAFLD in human (42), Lis1 KO animal model has revealed several key molecular processes that recapitulate the major features of NAFLD progression: hepatocyte damage, inflammation, fibrosis, and progression to the development of liver tumor.